| Karen White, RN-BC BSN MSN | |
|
Unit 28038, Apo, AE 09112-8038 | |
| (314) 476-4726 | |
| Not Available |
| Full Name | Karen White |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Case Management |
| Location | Unit 28038, Apo, Armed Forces Europe |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1932523305 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WC0400X | Registered Nurse - Case Management | 778278 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Karen White, RN-BC BSN MSN Cmr 411 Box 3802, Apo, AE 09112-0039 Ph: (517) 250-0557 | Karen White, RN-BC BSN MSN Unit 28038, Apo, AE 09112-8038 Ph: (314) 476-4726 |
News Archive
Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer -; a finding that could upend the way scientists think about the origin of the disease.
Stryker Corporation announced today that its Board of Directors has modified its dividend policy to adopt a quarterly payment schedule in lieu of an annual dividend. In conjunction with this modification, the Company's Board of Directors has declared a cash transition dividend of $0.10 per share, payable December 16, 2009, to shareholders of record at the close of business on November 18, 2009.
The holidays are supposed to be a time for family togetherness and cheer, yet for many women and children, they are instead a time of fear and violence.
Tolerx, Inc., a biopharmaceutical company developing novel therapies to treat autoimmune diseases and cancer by modulating T cell activity, presented results from preclinical studies with TRX518, an early-stage agent Tolerx is developing as a treatment for cancer. TRX518 is a monoclonal antibody to glucocorticoid-induced tumor necrosis factor receptor (GITR) and is designed to enhance the immune system's ability to attack tumors by activating and rendering T effector cells resistant to T regulatory cell suppression.
An interview with Brendan O'Brien from Vision Direct, discussing everything from the types of contact lenses available to preventing 'dry eye' and the future potential of smart lenses!
› Verified 8 days ago
Mr. Kevin Travis Worth, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Cmr 457, Apo, AE 09033 Phone: 097-219-66222 | |
Megan Elizabeth Newnam, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Usa Meddac Bavaria, Cmr 411, Bldg 700, Rose Barracks, Apo, AE 09112 Phone: 011-499-662834719 Fax: 011-499-662834721 | |
Andrea Martin Ritz, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Cmr 402, Apo, AE 09180 Phone: 496-371-867704 Fax: 496-371-867250 | |
Ms. Kara N Granroth, DNP Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-7028 | |
George Alexander Sawczyn, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Lrmc, Cmr 402, Box 90, Apo, AE 09180 Phone: 063-718-68895 | |
Mary Grace Dunlop, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Unit 28747 Box 6537, Apo, AE 09177 Phone: 316-467-3227 | |
Sharon Rose Owen, BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Usa Meddac Bavaria, Cmr 411, Bldg 700, Rose Barracks, Apo, AE 09112 Phone: 499-662-834719 Fax: 499-662-834721 |